BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 6815597)

  • 1. Pituitary and ovarian response to luteinizing hormone releasing factor in normal and sulpiride-induced hyperprolactinemic women.
    Yagi S; Nakano R
    Obstet Gynecol; 1982 Nov; 60(5):571-6. PubMed ID: 6815597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pituitary and ovarian response to acute stimulation with LH-RH in normal and anovulatory women.
    Aparicio NJ; Casas PR; Galimberti DM; de Laborde NP; Badano A; García EP; Meichi HR; Mirkin A; Szejner M; Jaitt A; Margulies M; Rosner JM
    Int J Fertil; 1977; 22(1):6-15. PubMed ID: 18416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocrine consequences of continuous antiestrogen therapy with tamoxifen in premenopausal women.
    Sherman BM; Chapler FK; Crickard K; Wycoff D
    J Clin Invest; 1979 Aug; 64(2):398-404. PubMed ID: 110834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of chronic sulpiride-induced hyperprolactinemia on menstrual cycles of normal women.
    Oseko F; Morikawa K; Motohashi T; Aso T
    Obstet Gynecol; 1988 Aug; 72(2):267-71. PubMed ID: 3134632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypersensitivity of the human gonadotrophs to the repeated administration of small doses of LH-RH.
    Faure N; Olivier GC
    Horm Res; 1978; 9(1):12-21. PubMed ID: 338460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LHRH and steroid levels in normal ovulatory women.
    Stone SC; Dickey RP; Kastin AJ; Schally AV
    Obstet Gynecol; 1976 Aug; 48(2):146-9. PubMed ID: 781572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct evidence of estrogen modulation of pituitary sensitivity to luteinizing hormone-releasing factor during the menstrual cycle.
    Wang CF; Yen SS
    J Clin Invest; 1975 Jan; 55(1):201-4. PubMed ID: 1088908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in pituitary and ovarian hormones following injection of ultra low dose LH-RH in normal and amenorrhoeic women.
    Newton J; Williams CV
    Acta Eur Fertil; 1975 Dec; 6(4):323-9. PubMed ID: 766551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of exogenous estrogen and progestin on pituitary responsiveness to synthetic luteinizing hormone-releasing factor.
    Vandenberg G; DeVane G; Yen SS
    J Clin Invest; 1974 Jun; 53(6):1750-4. PubMed ID: 4598115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pituitary responsiveness to LHRH and TRH in adolescent girls.
    Lemarchand-Béraud T; Zufferey M; Reymond M; Rey-Stocker I
    Bull Schweiz Akad Med Wiss; 1978 Mar; 34(1-3):241-54. PubMed ID: 96896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in pituitary sensitivity to GnRH in estrogen-treated post-menopausal women: evidence that gonadotrophin surge attenuating factor plays a physiological role.
    Dafopoulos K; Kotsovassilis CG; Milingos S; Kallitsaris A; Galazios G; Zintzaras E; Sotiros P; Messinis IE
    Hum Reprod; 2004 Sep; 19(9):1985-92. PubMed ID: 15229199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.
    Krause BT; Ohlinger R
    Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):87-92. PubMed ID: 16377065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progesterone feedback in normal and sulpiride-induced hyperprolactinemic postmenopausal women.
    Nakano R; Nishi T
    Obstet Gynecol; 1989 Apr; 73(4):617-21. PubMed ID: 2494622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pituitary response to a new analog of luteinizing hormone releasing factor during the menstrual cycle.
    Nakano R; Takekida H; Kotsuji F; Tojo S
    Obstet Gynecol; 1975 Mar; 45(3):263-6. PubMed ID: 1089930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levonorgestrel administration in emergency contraception: bleeding pattern and pituitary-ovarian function.
    Tirelli A; Cagnacci A; Volpe A
    Contraception; 2008 May; 77(5):328-32. PubMed ID: 18402847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma endothelin and LH-RH, LH, FSH, prolactin, progesterone, 17alpha-hydroxyprogesterone, estrone, 17beta-estradiol, delta4-androstenedione, testosterone, active renin, angiotensin-II and ANP levels in blood and LH, estrone and 17beta-estradiol and pregnanediol levels in urine of normal cycling women.
    Usuki S; Kondoh K; Kubo T
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S421-7. PubMed ID: 11078439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical estradiol secretion and ovulation patterns caused by luteal out-of-phase (LOOP) events underlying irregular ovulatory menstrual cycles in the menopausal transition.
    Hale GE; Hughes CL; Burger HG; Robertson DM; Fraser IS
    Menopause; 2009; 16(1):50-9. PubMed ID: 18978637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The sensibility of the hypophysis, the gonads and the thyroid of adolescents before and after the administration of oral contraceptives. A resume.
    Rey-Stocker I; Zufferey MM; Lemarchand MT; Rais M
    Pediatr Ann; 1981 Dec; 10(12):15-20. PubMed ID: 6801609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No evidence for pituitary priming to gonadotropin-releasing hormone in relation to luteinizing hormone (LH) secretion prior to the preovulatory LH surge in ewes.
    Crawford JL; McNeilly JR; McNeilly AS
    Biol Reprod; 2004 Jul; 71(1):224-35. PubMed ID: 15031142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ghrelin on gonadotrophin secretion in women during the menstrual cycle.
    Messini CI; Dafopoulos K; Chalvatzas N; Georgoulias P; Messinis IE
    Hum Reprod; 2009 Apr; 24(4):976-81. PubMed ID: 19095668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.